PortfoliosStock ScreensStocksStockXcel

Suven Life Sciences Limited

SUVEN | BSE

82.88

INR

-0.13

-0.16%

SUVEN | BSE

About Suven Life Sciences Limited

Sector

Healthcare

Industry

Drug Manufacturers-Specialty & Generic

Earnings date

30/09/2023

As of date

08/12/2023

Close

82.88

Open

82.86

High

84.79

Low

82.45

Suven Life Sciences Limited a clinical-stage biopharmaceutical company focuses on the acquisition development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India the United States Europe and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include SUVN-502 for the treatment of Alzheimer's disease and neuropsychiatric symptoms; SUVN-G3031 a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and SUVN-911 a novel potent and selective a4ß2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. The company is also developing SUVN-D4010 a potent selective and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders and schizophrenia; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

View Less

SUVEN | BSE

Risk
36.9%
Sharpe
0.45
Luna's Score
39/100
Recommendation
Sell

Luna says (SUVEN | BSE)

What's Working

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

What's not Working

Negative Momentum (Declining Price)

Weakness based on declining price with high volume

Price Below SMA10D

Microcap (<300M USD)

No Dividends (Dividend Yield = 0%)

High Market Beta (> 0.8)

Weak Operating Margin (< 10%)

Declining Revenue (< 0%)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

10 days

21.4%

1 month

36.9%

3 months

61.5%

6 months

49.7%

Return

Fundamental Ratios

PE

0

Fwd. PE

0

Price to book

5.31

Debt to equity

0.00

Debt to assets

0.00

Ent. to EBITDA

-14.75

Ent. to rev.

128.28

PEG

0

Other Fundamentals

EBITDA

-1.35B

MarketCap

18.07B

MarketCap(USD)

216.70M

Div. yield

0

Op. margin

-824.83

Erngs. growth

1.56K

Rev. growth

-30.30

Ret. on equity

-58.51

Short ratio

0

Short perc.

0

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bullish (SMA1M > SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Range10D

4.95

Range1M

7.81

Range3M

27.90

Volumes: Market Activity

Rel. volume

1.34

Price X volume

5.75M

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007